HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark R Pittelkow Selected Research

Mycosis Fungoides

10/2021Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
1/2021How to Sequence Therapies in Mycosis Fungoides.
12/2012Sézary syndrome: a study of 176 patients at Mayo Clinic.
3/2006A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
6/2005Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark R Pittelkow Research Topics

Disease

15Neoplasms (Cancer)
04/2020 - 02/2002
10Melanoma (Melanoma, Malignant)
11/2020 - 01/2002
9Psoriasis (Pustulosis Palmaris et Plantaris)
02/2014 - 02/2004
6Inflammation (Inflammations)
07/2022 - 04/2004
6Pemphigus (Pemphigus Vulgaris)
11/2015 - 03/2004
5Mycosis Fungoides
10/2021 - 06/2005
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2020 - 01/2005
4Neoplasm Metastasis (Metastasis)
01/2020 - 01/2002
4Skin Diseases (Skin Disease)
04/2015 - 01/2005
4Atopic Dermatitis (Atopic Eczema)
07/2012 - 09/2006
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2006 - 08/2004
3Skin Neoplasms (Skin Cancer)
04/2022 - 08/2007
3Dermatitis
03/2021 - 08/2010
3Lymphoma (Lymphomas)
01/2021 - 06/2005
3Celiac Disease (Celiac Sprue)
01/2015 - 02/2008
3Acantholysis
01/2013 - 03/2004
3Vasculitis (Vasculitides)
02/2012 - 06/2006
3Dermatitis Herpetiformis (Disease, Duhring's)
02/2012 - 10/2004
3Nephrogenic Fibrosing Dermopathy
01/2011 - 08/2006
2Infections
07/2022 - 06/2002
2Exanthema (Rash)
03/2021 - 10/2004
2Gangrene
01/2021 - 08/2006
2Actinic Keratosis
04/2020 - 10/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 07/2002
2Immunoglobulin G4-Related Disease
04/2015 - 02/2014
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2011 - 03/2011
2Exfoliative Dermatitis (Erythroderma)
08/2008 - 03/2006
2Calciphylaxis
04/2007 - 09/2004
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2005 - 07/2002
2Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2005 - 12/2002
1Pityriasis Rubra Pilaris
11/2022
1Wounds and Injuries (Trauma)
07/2022
1Lichen Planus (Lichen Ruber Planus)
01/2022
1Pseudolymphoma
09/2021
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2021
1Raynaud Disease (Raynaud's Disease)
01/2021
1Migraine Disorders (Migraine)
01/2021
1Disease Progression
01/2021
1Panniculitis
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Ataxia (Dyssynergia)
10/2020
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
10/2020
1Lymphomatoid Papulosis
09/2020
1Plasmablastic Lymphoma
01/2020

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2002
4Pharmaceutical PreparationsIBA
11/2022 - 06/2005
4Immunoglobulin G (IgG)IBA
02/2014 - 03/2004
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2010 - 02/2002
3AutoantibodiesIBA
01/2013 - 03/2004
3Glutens (Glutelin)IBA
02/2012 - 10/2004
2Secretory Leukocyte Peptidase InhibitorIBA
07/2022 - 04/2004
2Sunscreening Agents (Sunscreens)IBA
04/2022 - 08/2007
2CytokinesIBA
01/2022 - 03/2010
2Rituximab (Mabthera)FDA Link
09/2021 - 01/2019
2Methotrexate (Mexate)FDA LinkGeneric
09/2021 - 03/2021
2Biological ProductsIBA
10/2020 - 11/2013
2Inositol (Myoinositol)IBA
04/2020 - 10/2010
2Interleukin-8 (Interleukin 8)IBA
01/2020 - 12/2002
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2020 - 09/2004
2Inositol Polyphosphate 5-PhosphatasesIBA
03/2019 - 10/2010
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2019 - 01/2005
2Lenalidomide (CC 5013)FDA Link
08/2016 - 03/2011
2Immunoglobulins (Immunoglobulin)IBA
04/2015 - 02/2014
2Isotretinoin (Accutane)FDA LinkGeneric
01/2015 - 12/2014
2Immunomodulating AgentsIBA
01/2014 - 07/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2012 - 03/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2012 - 04/2007
2RetinoidsIBA
04/2012 - 06/2005
2GadoliniumIBA
01/2011 - 08/2009
2sargramostim (Leukine)FDA Link
12/2008 - 02/2002
2HLA-A2 Antigen (HLA A2 Antigen)IBA
12/2008 - 08/2006
2Immunoglobulin A (IgA)IBA
02/2008 - 01/2005
2Adrenergic Agents (Adrenergic Drugs)IBA
10/2007 - 09/2006
2AmphiregulinIBA
06/2005 - 06/2004
1Monoclonal AntibodiesIBA
11/2022
1secukinumabIBA
11/2022
1ixekizumabIBA
11/2022
1InterleukinsIBA
11/2022
1Antiviral Agents (Antivirals)IBA
07/2022
1Peptide Hydrolases (Proteases)FDA Link
07/2022
1ruxolitinibIBA
01/2022
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1Janus Kinase 1IBA
01/2022
1AcidsIBA
10/2021
1mogamulizumabIBA
03/2021
1Calcitonin Gene-Related PeptideIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1pazopanibFDA Link
01/2021
1polyglutamineIBA
10/2020
1Ataxin-3IBA
10/2020
1IntegrinsIBA
01/2020

Therapy/Procedure

22Therapeutics
09/2021 - 07/2002
3Photopheresis
03/2021 - 02/2002
2Photochemotherapy (Photodynamic Therapy)
10/2021 - 09/2020
2Transplantation
01/2017 - 04/2012
2Parathyroidectomy
10/2016 - 04/2007
2Drug Therapy (Chemotherapy)
12/2005 - 06/2002
2Mohs Surgery (Mohs' Micrographic Surgery)
01/2005 - 08/2004
1Protective Clothing
04/2022
1Surgical Amputation (Amputations)
01/2021